Home  /  Resource Library  /  Clinical and radiographic predictors of progression and survival in relapsed/refractory lymphoma patients receiving anti-CD19 CAR T-cell therapy

Clinical and radiographic predictors of progression and survival in relapsed/refractory lymphoma patients receiving anti-CD19 CAR T-cell therapy

Study examined predictive factors in patients responses to CAR-T therapy.